FDA Approvals and Clinical Trials Increase Treatment Options for MCL Patients

Choices in frontline therapy for mantle cell lymphoma are changing rapidly, giving patients hope for the future. Watch as Dr. Joshua Brody shares the latest MCL treatment research from ASH 2019.

Read the full article here

Related Articles